[@RenaissancePeriodization] The First FDA Approved Muscle Growth Drug Is Here! Here’s the Catch.
Link: https://youtu.be/HuEQ0hEWI7Y
Duration: 12 min
Transcript: Download plain text
Short Summary
The FDA approved apitegromab, the first myostatin inhibitor, a monoclonal antibody developed by Scholar Rock, though the episode emphasizes it is currently impractical for fitness enthusiasts. In trials, a low dose preserved 4 lb more muscle over 24 weeks when combined with weight-loss drugs, and bimagrumab plus tirzepatide cut lean mass loss by 55% without blocking fat loss. The host predicts cheaper, more accessible myostatin inhibitors will arrive within 3–5 years, potentially transforming both public health and gym culture.
![[@RenaissancePeriodization] Summarizer](https://summaries.pages.dev/img/logo.webp)








